The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Abstract
Alzheimer's disease, a neurodegenerative disease with amyloid beta accumulation as a major hallmark, has become a dire global health concern as there is a lack of clear understanding of the causative agent. It is a major cause of dementia which is increasing exponentially with age. Alzheimer's disease is marked by tau hyperphosphorylation and amyloid beta accumulation that robs people of their memories. Amyloid beta deposition initiated a spectrum of microglia-activated neuroinflammation, and microglia and astrocyte activation elicited expressions of various inflammatory and anti-inflammatory cytokines. Neuroinflammation is one of the cardinal features of Alzheimer's disease. Pro-inflammatory cytokine signaling plays multifarious roles in neurodegeneration and neuroprotection. Induction of proinflammatory signaling leads to discharge of immune mediators which affect functions of neurons and cause cell death. Sluggish anti-inflammatory system also contributes to neuroinflammation. Numerous pathways like NFκB, p38 MAPK, Akt/mTOR, caspase, nitric oxide, and COX are involved in triggering brain immune cells like astrocytes and microglia to secrete inflammatory cytokines such as tumor necrosis factor, interleukins, and chemokines and participate in Alzheimer's disease pathology. PPAR-γ agonists tend to boost the phagocytosis of amyloid beta and decrease the inflammatory cytokine IL-1β. Recent findings suggest the cross-link between gut microbiota and neuroinflammation contributing…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several pathological factors in AD, such as Aβ, pro-inflammatory cytokines, and oxidative stress, activate microglia and initiate downstream signaling pathways such as MAPK, NF-κB, and PI3K/Akt.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [239]
In the citing paper
“The activation of these pathways further promotes the activation of microglia and the production of inflammatory mediators, exacerbating neurotoxicity.238–240”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [239]
In the citing paper
“NF-κB can be co-regulated by multiple pathways including MAPK and PI3K/Akt to enhance transcriptional activity, thus promoting the expression of pro-inflammatory and pro-oxidant enzyme genes.239,243,244”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [239]
Citations
Cites
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791 · cited 1×
“This aggregated Aβ binds to c1q and activates the complement pathway, leading to clearance of Aβ [20].”
BackgroundNeuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“A plethora of mechanisms are involved in AD pathology, including neuroinflammation, oxidative stress, and mitochondrial dysfunction that contribute to AD [15].”
BackgroundNeuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · cited 1×
“AD-related inflammatory components which result in neuroinflammation include microglia and astrocyte cells of the brain, the complement system, cytokines, and chemokines [16].”
BackgroundInflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253 · cited 1×
“Inflammation is an important factor in various metabolic disorders such as diabetes, atherosclerosis, and multiple sclerosis, and also in neurodegenerative diseases such as AD [11].”
BackgroundDinarello, C. A. (2000) · Chest · doi:10.1378/chest.118.2.503 · Cited by 2,045
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · cited 1×
“CNS and release cytokines and chemokines along with macrophage like activity [9].”
BackgroundRole of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288 · cited 6×
“TLRs are highly expressed in CNS and neurons.”
BackgroundInfluentialWang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., Xie, Z., Chu, X., Yang, J., Wang, H., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0216-x · Cited by 1,144 · cited 1×
“It also prevents the brain from attack of peripheral immune cells and preventing the brain from neuroinflammation induced damage [66, 67].”
BackgroundA Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839 · cited 1×
“IL-10 interacts with cell surface receptors (IL-10Rs) found on glial cell in the brain region and is said to limit inflammation by decreasing synthesis of various proinflammatory cytokines, suppress cytokines receptor like IL-1 and TNF α, and inhibit activation of receptor in the brain [42].”
BackgroundNorden, D. M., Trojanowski, P. J., Villanueva, E., Navarro, E., & Godbout, J. P. (2016) · Glia · doi:10.1002/glia.22930 · Cited by 590 · cited 2×
“Neuroinflammation is mediated by various cytokines, chemokines, ROS, etc. Released mediators are a response to microglia and astrocytes.”
Background
Research works printed but not linked: 10
- Sahab Uddin, Md, Abdullah Al Mamun, Md Tanvir Kabir, & Ghulam, Md Ashraf, May N Bin-Jumah, and Mohamed M Abdel-Daim. Multi-target drug candidates for multifactorial Alzheimer’s disease: AChE and NMDAR as molecular targets. https://doi.org/10.1007/s12035-020-02116-9/Published. · doi:10.1007/s12035-020-02116-9/published
- Shal, Bushra, Wei Ding, Hussain Ali, Yeong S. Kim, and Salman Khan. 2018. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease. Frontiers in Pharmacology 9. Frontiers Media S.A.: 548. https://doi.org/10.3389/FPHAR.2018.00548/BIBTEX. · doi:10.3389/fphar.2018.00548/bibtex
- Figueiredo-Pereira, Maria E., Patricia Rockwell, Thomas Schmidt-Glenewinkel, and Peter Serrano. 2015. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration. Frontiers in Molecular Neuroscience 7. Frontiers Media S.A.: 1–20. https://doi.org/10.3389/FNMOL.2014.00104/BIBTEX. · doi:10.3389/fnmol.2014.00104/bibtex
- Liu et al. - 2017 - NF-κB signaling in inflammation - Signal Transduction and Targeted Therapy.pdf. · DOI · Paper page
- Mueed, Zeba, Pallavi Tandon, Sanjeev Kumar Maurya, Ravi Deval, Mohammad A. Kamal, and Nitesh Kumar Poddar. 2019. Tau and mTOR: the hotspots for multifarious diseases in Alzheimer’s development. Frontiers in Neuroscience 13. Frontiers Media S.A.: 1017. https://doi.org/10.3389/FNINS.2018.01017/BIBTEX. · doi:10.3389/fnins.2018.01017/bibtex
- Uddin, Md Sahab, Md Ataur Rahman, Md Tanvir Kabir, Tapan Behl, Bijo Mathew, Asma Perveen, George E. Barreto, May N. Bin-Jumah, Mohamed M. Abdel-Daim, and Ghulam Md Ashraf. 2020. Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer’s disease. IUBMB Life 72. John Wiley & Sons, Ltd: 1843–1855. https://doi.org/10.1002/IUB.2324. · DOI
- Lin, Li, Li Juan Zheng, and Long Jiang Zhang. 2018. Neuroinflammation, gut microbiome, and Alzheimer’s disease. Molecular Neurobiology 55. Humana Press Inc.: 8243–8250. https://doi.org/10.1007/S12035-018-0983-2/FIGURES/2. · doi:10.1007/s12035-018-0983-2/figures/2
- Zhao, Yang, Jianshuai He, Ning Yu, Changxin Jia, and Shilei Wang. 2020. Mechanisms of dexmedetomidine in neuropathic pain. Frontiers in Neuroscience 14. Frontiers Media S.A.: 330. https://doi.org/10.3389/FNINS.2020.00330/BIBTEX. · doi:10.3389/fnins.2020.00330/bibtex
- Prins, Niels D., John E. Harrison, Hui May Chu, Kelly Blackburn, John J. Alam, Philip Scheltens, Arnold, et al. 2021. A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease. Alzheimer’s Research and Therapy 13. BioMed Central Ltd: 1–12. https://doi.org/10.1186/S13195-021-00843-2/TABLES/3. · doi:10.1186/s13195-021-00843-2/tables/3
- Guo, Libing, Jiaxin Xu, Yunhua Du, Weibo Wu, Wenjing Nie, Dongliang Zhang, Yuling Luo, et al. 2021. Effects of gut microbiota and probiotics on Alzheimer’s disease. Translational Neuroscience 12. De Gruyter Open Ltd: 573–580. https://doi.org/10.1515/TNSCI-2020-0203/ASSET/GRAPHIC/J_TNSCI-2021-0203_FIG_001.JPG. · doi:10.1515/tnsci-2020-0203/asset/graphic/j_tnsci-2021-0203_fig_001.jpg
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
“It seems obvious that there is a need to identify the optimal time window in which inhibition of NO production could exert the most clinical efficacy 524,525 .”
Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues
Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324
“Neurofibrillary tangles within the neuronal cells and senile plaques outside the cells are the two characteristic features of AD [1, 2].”
BackgroundSelf-citationOxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Dhapola, R., Beura, S. K., Sharma, P., Singh, S. K., & HariKrishnaReddy, D. (2024) · Molecular Biology Reports · doi:10.1007/s11033-023-09021-z · Cited by 252
“It is an anti-TNF-α drug efficient in reducing cognitive defects in AD patients [107, 108].”
Self-citationSarapultsev, A., Gusev, E., Komelkova, M., Utepova, I., Luo, S., & Hu, D. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00151-1 · Cited by 221
“Neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease, often exhibit low-grade chronic neuroinflammation manifestations [313, 314].”
Background
Metadata
- Authors
- Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H.
- Affiliations
- Central University of Punjab (IN)
- All India Institute of Medical Sciences, Mangalagiri (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- Venue
- Inflammation
- Published
- 2022-08-20
- Volume
- 46
- Issue
- 1
- Pages
- 1-17
- ISSN
- 0360-3997 (ISSN-L)
- 1573-2576
- OpenAlex
- W4294094040
- Cited by
- 557
- References
- 55
- Citations by year
- 2026: 151 · 2025: 209 · 2024: 146 · 2023: 46 · 2022: 5
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Inflammation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, amyloid-beta, tau hyperphosphorylation, microglial activation, astrocyte activation, inflammatory cytokines, anti-inflammatory cytokines, NF-κB signaling, p38 MAPK, Akt/mTOR signaling, caspases, nitric oxide, Cox, PPARγ agonists, gut microbiota, neuroprotection, neurodegeneration, anti-inflammatory agents
- MeSH terms
- Neuroinflammatory Diseases, Alzheimer Disease, Anti-Inflammatory Agents, Humans, Cytokines, Amyloid beta-Peptides, Microglia, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics. https://app.cochat.ai/papers/10.1007/s10753-022-01721-1
- The paper
- Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023). Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation. https://doi.org/10.1007/s10753-022-01721-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.